▼ -70.25% Downside Potential
This price target is based on 16 analysts offering 12 month price targets for HEXO in the last 3 months. The average price target is $1.95, with a high forecast of $8.00 and a low forecast of $0.75. The average price target represents a -70.25% upside from the last price of $6.54.
The current consensus among 16 polled investment analysts is to hold stock in HEXO. This Hold consensus rating has held steady for over two years.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.